Living Systematic Review of Therapeutic Options for Post Acute or Post COVID-19 Condition
| dc.date.accessioned | 2023 | |
| dc.date.available | 2023 | |
| dc.date.issued | 2023 | |
| dc.identifier.govdoc | PAHO/IMS/EIH/COVID-19/23-0006 | |
| dc.identifier.uri | https://iris.paho.org/handle/10665.2/57278 | |
| dc.description.abstract | This review compiles the evidence on potential therapeutic options for post-COVID-19 conditions (PCC). Included are all the identified clinical forms, symptoms, and manifestations of PCC for which an intervention was assessed in at least one randomized controlled trial. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | PAHO | en_US |
| dc.rights | Attribution-NonCommercial-ShareAlike 3.0 IGO | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/igo/ | * |
| dc.subject | COVID-19 | en_US |
| dc.subject | SARS-CoV-2 | en_US |
| dc.subject | Coronavirus Infections | en_US |
| dc.subject | Therapeutical Approaches | en_US |
| dc.subject | Knowledge Translation | en_US |
| dc.title | Living Systematic Review of Therapeutic Options for Post Acute or Post COVID-19 Condition | en_US |
| dc.type | Technical reports | en_US |
| dc.rights.holder | Pan American Health Organization | en_US |
| dc.contributor.corporatename | Pan American Health Organization | en_US |
| paho.isfeatured | 0 | en_US |
| paho.publisher.country | United States | en_US |
| paho.publisher.city | Washington, D.C. | en_US |
| paho.source.centercode | US1.1 | en_US |
| paho.contributor.department | Evidence and Intelligence for Action in Health (EIH) | en_US |
| paho.iswhotranslation | No | en_US |
Files in this item
This item appears in the following Collection(s)
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Related items
Showing items related by title, author, creator and subject.
-
(PAHOUnited StatesWashington, D.C., 2020)Take home message thus far: • We examined 24 therapeutic options thus far; currently, there is no evidence of any important benefit from any therapeutic option (though remdesivir is revealing promise as one option based ...
-
(PAHOUnited StatesWashington, D.C., 2020)More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, we have examined 40 therapeutic options. The Pan American Health Organization (PAHO) is ...
-
(PAHOUnited StatesWashington, D.C., 2020)More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, we examined 30 therapeutic options.
